When babies are born with HIV, starting treatment within hours to days is better than waiting even the few weeks to months that's the norm in many countries, researchers reported Wednesday.
Nov 27, 2019
0
42
University of Pittsburgh School of Medicine scientists have identified drug candidates that show promise to reverse the ability of HIV to escape detection by the immune system.
Mar 19, 2024
0
28
Researchers from Boston University School of Medicine (BUSM) and Fenway Health have found that highly active antiretroviral therapy (HAART) does not completely suppress HIV in the semen of sexually active HIV-infected men ...
Mar 27, 2012
0
0
Understanding HIV latency at the molecular level is crucial for efforts to eliminate the viral scourge that causes AIDS. Latent infected cell reservoirs—where the human immunodeficiency virus (HIV) hides and persists in ...
Jan 10, 2023
0
54
(AP) -- Business and social media leaders teamed up Friday to tackle the transmission of HIV from mothers to babies, saying the medicine and the money are largely in place, and with the right organizational skills they can ...
Jan 27, 2012
0
0
A vaccine containing a protein necessary for virus replication can boost an HIV-infected patient's immune system, according to clinical research published in the open access journal Retrovirology. This boost can result in ...
Apr 28, 2015
0
23
Of the 38 million people worldwide living with HIV, approximately 700,000 are newly infected men, primarily via sexual transmission. Sexually transmitted HIV infections in exclusively heterosexual men are acquired through ...
Jun 12, 2023
0
7
Just a few years ago, anyone who talked of a cure for the AIDS virus would in all likelihood have met with a sad, ironic smile.
Jul 19, 2011
0
0
A research team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a group of recently discovered antibodies may be a highly effective therapy for the treatment of HIV. Published on-line ...
Oct 30, 2013
1
0
(HealthDay)—Slow-release implantable naltrexone is associated with better outcomes than the oral drug for HIV-positive patients with an opioid addiction, according to a study published in the April issue of The Lancet HIV.
Apr 19, 2019
0
1
